01 1Zhejiang Huahai Pharmaceutical Co. , Ltd.
01 1Nevirapine
01 1China
Registration Number : 227MF10149
Registrant's Address : Xunqiao, Linhai, Zhejiang 317024, China
Initial Date of Registration : 2015-05-26
Latest Date of Registration : 2021-03-17
66
PharmaCompass offers a list of Nevirapine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Nevirapine manufacturer or Nevirapine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Nevirapine manufacturer or Nevirapine supplier.
PharmaCompass also assists you with knowing the Nevirapine API Price utilized in the formulation of products. Nevirapine API Price is not always fixed or binding as the Nevirapine Price is obtained through a variety of data sources. The Nevirapine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A BI-RG-587 & CD4-IgG manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of BI-RG-587 & CD4-IgG, including repackagers and relabelers. The FDA regulates BI-RG-587 & CD4-IgG manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. BI-RG-587 & CD4-IgG API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of BI-RG-587 & CD4-IgG manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A BI-RG-587 & CD4-IgG supplier is an individual or a company that provides BI-RG-587 & CD4-IgG active pharmaceutical ingredient (API) or BI-RG-587 & CD4-IgG finished formulations upon request. The BI-RG-587 & CD4-IgG suppliers may include BI-RG-587 & CD4-IgG API manufacturers, exporters, distributors and traders.
click here to find a list of BI-RG-587 & CD4-IgG suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The BI-RG-587 & CD4-IgG Drug Master File in Japan (BI-RG-587 & CD4-IgG JDMF) empowers BI-RG-587 & CD4-IgG API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the BI-RG-587 & CD4-IgG JDMF during the approval evaluation for pharmaceutical products. At the time of BI-RG-587 & CD4-IgG JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of BI-RG-587 & CD4-IgG suppliers with JDMF on PharmaCompass.
We have 1 companies offering BI-RG-587 & CD4-IgG
Get in contact with the supplier of your choice:
